πŸ‡ΊπŸ‡Έ FDA
Patent

US 6645941

6,11-3C-bicyclic 9a-azalide derivatives

expired A61PA61P31/04

Quick answer

US patent 6645941 (6,11-3C-bicyclic 9a-azalide derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Nov 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P31/04